文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多学科心脏团队指导下的复杂冠状动脉疾病管理后的长期生存情况。

Long-term survival after multidisciplinary heart team-guided management of complex coronary artery disease.

作者信息

Pickering Taylor, Kluis Austin, Shih Emily, Squiers John J, McCullough Kyle, Dorton Cody, Moore David O, Potluri Srinivasa P, Szerlip Molly, Al-Azizi Karim, Moubarak Ghadi, Ladner Jonathan, Vaishnav Radhika, McCoy Shelby, Ejiofor Julius, Sawhney Rahul, Hale Sarah, Schaffer Justin M, Banwait Jasjit, Harrington Katherine B, Brinkman William T, Hafen Lee R, Smith Robert L, George Timothy J, DiMaio J Michael, Ryan William H, Hutcheson Kelley A

机构信息

Baylor Scott & White Research Institute, Plano, Texas, USA.

Department of Cardiothoracic Surgery, Baylor Scott & White The Heart Hospital - Plano, Plano, Texas, USA.

出版信息

Proc (Bayl Univ Med Cent). 2025 Jun 20;38(5):589-597. doi: 10.1080/08998280.2025.2516981. eCollection 2025.


DOI:10.1080/08998280.2025.2516981
PMID:40821489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12351742/
Abstract

OBJECTIVE: Guidelines recommend a multidisciplinary heart team approach for managing complex coronary artery disease (CAD), yet its impact on clinical outcomes and adherence to recommendations is rarely reported. METHODS: Between June 2021 and August 2022, 210 high-risk patients with isolated, complex CAD were evaluated at our institution's weekly heart team conference for consideration of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), hybrid PCI/CABG, or optimal medical therapy (OMT). Adherence to recommendations and clinical outcomes, including 30-day, 1-year, and 2-year mortality, were assessed. RESULTS: Overall adherence to heart team recommendations was 92%, with 96% adherence for CABG, 90% for PCI, 87% for OMT, and 75% for hybrid PCI/CABG. CABG was the most frequently recommended treatment (53%) and demonstrated the lowest mortality at 1 year (4%) and 2 years (6%) compared with PCI (1 year, 28%; 2 year, 40%) and OMT (1 year, 10%; 2 year, 20%). CABG patients had a lower-than-expected mortality (observed-to-expected ratio 0.9), while PCI was associated with significantly higher mortality (observed-to-expected ratio 3.0). CONCLUSION: This single-center multidisciplinary heart team approach for complex CAD offers a collaborative, patient-centered model that facilitates high adherence rates and favorable patient outcomes. These findings highlight the potential benefits of integrating multidisciplinary evaluation and support its implementation into standard practice for high-risk CAD patients.

摘要

目的:指南推荐采用多学科心脏团队方法来管理复杂冠状动脉疾病(CAD),但其对临床结局和推荐意见依从性的影响鲜有报道。 方法:在2021年6月至2022年8月期间,在我们机构每周的心脏团队会议上对210例孤立性、复杂性CAD高危患者进行评估,以考虑冠状动脉旁路移植术(CABG)、经皮冠状动脉介入治疗(PCI)、杂交PCI/CABG或最佳药物治疗(OMT)。评估对推荐意见的依从性和临床结局,包括30天、1年和2年死亡率。 结果:对心脏团队推荐意见的总体依从率为92%,CABG的依从率为96%,PCI为90%,OMT为87%,杂交PCI/CABG为75%。CABG是最常被推荐的治疗方法(53%),与PCI(1年,28%;2年,40%)和OMT(1年,10%;2年,20%)相比,其1年(4%)和2年(6%)死亡率最低。CABG患者的死亡率低于预期(观察到的与预期的比率为0.9),而PCI则与显著更高的死亡率相关(观察到的与预期的比率为3.0)。 结论:这种针对复杂CAD的单中心多学科心脏团队方法提供了一种协作性、以患者为中心的模式,有助于提高依从率并使患者获得良好结局。这些发现凸显了整合多学科评估的潜在益处,并支持将其纳入高危CAD患者的标准治疗实践中。

相似文献

[1]
Long-term survival after multidisciplinary heart team-guided management of complex coronary artery disease.

Proc (Bayl Univ Med Cent). 2025-6-20

[2]
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.

JAMA. 2013-11-20

[3]
Comparing AI-Driven and Heart Team Decision-Making in Multivessel Coronary Artery Disease.

J Clin Med. 2025-6-23

[4]
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.

Lancet. 2018-2-23

[5]
Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.

Catheter Cardiovasc Interv. 2025-7-1

[6]
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Health Technol Assess. 2008-6

[7]
Exercise-based cardiac rehabilitation for coronary heart disease.

Cochrane Database Syst Rev. 2021-11-6

[8]
Ten-year outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for multivessel or left main coronary artery disease: a systematic review and meta-analysis.

J Cardiothorac Surg. 2023-2-2

[9]
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.

Ann Intern Med. 2007-11-20

[10]
Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.

JACC Cardiovasc Interv. 2013-12

本文引用的文献

[1]
Institution of a formal multidisciplinary heart team for high-risk coronary revascularization.

Proc (Bayl Univ Med Cent). 2024-11-22

[2]
The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges.

JACC Adv. 2023-1-11

[3]
Impact of Incomplete Revascularization After PCI in Left Main Disease: The EXCEL Trial.

Circ Cardiovasc Interv. 2024-3

[4]
Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease.

Sci Rep. 2023-12-15

[5]
The experiences of patients with advanced heart failure, family carers, and health professionals with palliative care services: a secondary reflexive thematic analysis of longitudinal interview data.

BMC Palliat Care. 2023-8-10

[6]
Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence.

Curr Treat Options Oncol. 2023-5

[7]
Ten-year outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for multivessel or left main coronary artery disease: a systematic review and meta-analysis.

J Cardiothorac Surg. 2023-2-2

[8]
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation. 2022-1-18

[9]
Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention.

J Am Coll Cardiol. 2021-7-20

[10]
Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease.

JAMA Netw Open. 2020-8-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索